Jones Christopher, Garuti Rita, Michaely Peter, Li Wei-Ping, Maeda Nobuyo, Cohen Jonathan C, Herz Joachim, Hobbs Helen H
Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
J Clin Invest. 2007 Jan;117(1):165-74. doi: 10.1172/JCI29415.
Genetic defects in LDL clearance result in severe hypercholesterolemia and premature atherosclerosis. Mutations in the LDL receptor (LDLR) cause familial hypercholesterolemia (FH), the most severe form of genetic hypercholesterolemia. A phenocopy of FH, autosomal recessive hypercholesterolemia (ARH), is due to mutations in an adaptor protein involved in LDLR internalization. Despite comparable reductions in LDL clearance rates, plasma LDL levels are substantially lower in ARH than in FH. To determine the metabolic basis for this difference, we examined the synthesis and catabolism of VLDL in murine models of FH (Ldlr(-/-)) and ARH (Arh(-/-)). The hyperlipidemic response to a high-sucrose diet was greatly attenuated in Arh(-/-) mice compared with Ldlr(-/-) mice despite similar rates of VLDL secretion. The rate of VLDL clearance was significantly higher in Arh(-/-) mice than in Ldlr(-/-) mice, suggesting that LDLR-dependent uptake of VLDL is maintained in the absence of ARH. Consistent with these findings, hepatocytes from Arh(-/-) mice (but not Ldlr(-/-) mice) internalized beta-migrating VLDL (beta-VLDL). These results demonstrate that ARH is not required for LDLR-dependent uptake of VLDL by the liver. The preservation of VLDL remnant clearance attenuates the phenotype of ARH and likely contributes to greater responsiveness to statins in ARH compared with FH.
低密度脂蛋白清除的基因缺陷会导致严重的高胆固醇血症和早发性动脉粥样硬化。低密度脂蛋白受体(LDLR)的突变会导致家族性高胆固醇血症(FH),这是遗传性高胆固醇血症最严重的形式。FH的一种表型模拟,即常染色体隐性高胆固醇血症(ARH),是由参与LDLR内化的衔接蛋白突变引起的。尽管LDL清除率有类似程度的降低,但ARH患者的血浆LDL水平明显低于FH患者。为了确定这种差异的代谢基础,我们在FH(Ldlr(-/-))和ARH(Arh(-/-))的小鼠模型中研究了极低密度脂蛋白(VLDL)的合成和分解代谢。尽管VLDL分泌速率相似,但与Ldlr(-/-)小鼠相比,Arh(-/-)小鼠对高糖饮食的高脂血症反应大大减弱。Arh(-/-)小鼠的VLDL清除率明显高于Ldlr(-/-)小鼠,这表明在没有ARH的情况下,VLDL的LDLR依赖性摄取得以维持。与这些发现一致,Arh(-/-)小鼠(而非Ldlr(-/-)小鼠)的肝细胞内化了β迁移的VLDL(β-VLDL)。这些结果表明,肝脏对VLDL的LDLR依赖性摄取不需要ARH。VLDL残余物清除的保留减轻了ARH的表型,并且可能导致ARH与FH相比对他汀类药物有更大的反应性。